Erdafitinib and Ocular disorders
Result of checking the interaction of drug Erdafitinib and disease Ocular disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Erdafitinib can cause ocular disorders, including central serous retinopathy/retinal pigment epithelial detachment (CSR/RPED) resulting in visual field defect. Perform monthly ophthalmological examinations during the first 4 months of treatment and every 3 months afterwards, and urgently at any time for visual symptoms. Ophthalmological examination should include assessment of visual acuity, slit lamp examination, fundoscopy, and optical coherence tomography. Caution and close monitoring is advised in patients with retinal disorders. Follow manufacturers dose modification guidelines in patients at risk or with ocular adverse reactions.
Erdafitinib - zaburzenia oczu 
Erdafitinib - desordens oculares 
Erdafitinib - gangguan okular 
Erdafitinib - gangguan mata 
Erdafitinib - disturbi oculari 
Erdafitinib - troubles oculaires 
Erdafitinib - Augenerkrankungen 
Erdafitinib - trastornos oculares 
Erdafitinib - глазные расстройства 
Erdafitinib - oküler bozukluklar 
Erdafitinib - اضطرابات العين 
Erdafitinib - 眼疾